Real-World Evidence in Oncology: Opportunities and Limitations-Reference-Cited by-同舟云学术

Real-World Evidence in Oncology: Opportunities and Limitations

Published:2019-12-24 Issue:5 Volume:25 Page:e746-e752
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Di Maio Massimo¹,Perrone Francesco²,Conte Pierfranco³

Affiliation:

1. Department of Oncology, University of Turin; Ordine Mauriziano Hospital, Torino, Italy

2. Clinical Trial Unit, National Cancer Institute, IRCCS Fondazione Pascale, Napoli, Italy

3. Department of Surgery, Oncology and Gastroenterology, University of Padova and Oncologia Medica 2, Istituto Oncologico Veneto, I.R.C.C.S., Padova, Italy

Abstract

The analysis of real-world evidence to answer clinical and policy-relevant questions in the field of oncology has gained increased interest in recent years. This article highlights the strengths and weaknesses of the use of real-world evidence in cancer care.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.2019-0647

Reference29 articles.

1. Effectiveness in the absence of efficacy: Cautionary tales from real-world evidence;Karim;J Clin Oncol,2019

2. Real-world data: Towards achieving the achievable in cancer care;Booth;Nat Rev Clin Oncol,2019

3. Real-world evidence - What is it and what can it tell us?;Sherman;N Engl J Med,2016

4. Relevance of randomised controlled trials in oncology;Tannock;Lancet Oncol,2016

5. Real-world data for efficient health technology assessment;Hall;Eur J Cancer,2017

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population;European Journal of Cancer;2024-09

2. Palbociclib: Randomized Studies and Real-world Evidence as the Basis for Therapeutic Planning in Metastatic Breast Cancer;Geburtshilfe und Frauenheilkunde;2024-09

3. UK multicentre real-world data of the use of cyclin-dependent kinase 4/6 inhibitors in metastatic breast cancer;ESMO Real World Data and Digital Oncology;2024-09

4. Androgen Receptor Inhibitors in Patients With Nonmetastatic Castration-Resistant Prostate Cancer;JAMA Network Open;2024-08-27

5. Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma;OncoImmunology;2024-08-26